Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya
Shannen van Duijn(University of Amsterdam), Tobias F. Rinke de Wit(Amsterdam Institute for Global Health and Development), Micah J. June(Kenya Medical Research Institute), Alloys K’Oloo(Kenya Medical Research Institute), Albert Odhiambo(Great Lakes University of Kisumu), Simon Kariuki(Kamuzu Central Hospital), Nathalie Houben(PharmAccess Group), Robert Aroka(PharmAccess Group), Isdorah Akoth(Kenya Medical Research Institute), Mevis Omollo(Kenya Medical Research Institute), Emmanuel Milimo(PharmAccess Group), Gregory Ganda(Kenya School of Government), Hellen C. Barsosio(Liverpool School of Tropical Medicine), Simon Onsongo(Aga Khan Hospital, Kisumu), Teresa De Sanctis(PharmAccess Group), Kephas Otieno(Kenya Medical Research Institute), Charlotte Wilming(PharmAccess Group)
Cited by 10
Related Papers
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya
|Nature Microbiology|2016|114
Health disparities across the counties of Kenya and implications for policy makers, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Global Health|2018|105